PubMed:32917722
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 160-177 | Body_part | denotes | respiratory tract | http://purl.org/sig/ont/fma/fma265130 |
T2 | 394-410 | Body_part | denotes | epithelial cells | http://purl.org/sig/ont/fma/fma66768 |
T3 | 405-410 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T4 | 718-734 | Body_part | denotes | epithelial cells | http://purl.org/sig/ont/fma/fma66768 |
T5 | 729-734 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T6 | 767-783 | Body_part | denotes | epithelial cells | http://purl.org/sig/ont/fma/fma66768 |
T7 | 778-783 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T8 | 1069-1076 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 160-177 | Body_part | denotes | respiratory tract | http://purl.obolibrary.org/obo/UBERON_0000065 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 32-40 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T2 | 132-152 | Disease | denotes | bacterial infections | http://purl.obolibrary.org/obo/MONDO_0005113 |
T3 | 249-265 | Disease | denotes | viral infections | http://purl.obolibrary.org/obo/MONDO_0005108 |
T4 | 338-347 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T5 | 449-457 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T6 | 474-482 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T7 | 536-544 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T8 | 547-556 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T9 | 651-660 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T10 | 669-677 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T11 | 849-858 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T12 | 871-879 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T13 | 978-986 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T14 | 1148-1164 | Disease | denotes | viral infections | http://purl.obolibrary.org/obo/MONDO_0005108 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 92-95 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T2 | 270-274 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test |
T3 | 394-404 | http://purl.obolibrary.org/obo/CL_0000066 | denotes | epithelial |
T4 | 405-410 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T5 | 507-508 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T6 | 713-717 | http://purl.obolibrary.org/obo/CLO_0009524 | denotes | Vero |
T7 | 713-717 | http://purl.obolibrary.org/obo/CLO_0050515 | denotes | Vero |
T8 | 718-728 | http://purl.obolibrary.org/obo/CL_0000066 | denotes | epithelial |
T9 | 729-734 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T10 | 755-760 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T11 | 767-777 | http://purl.obolibrary.org/obo/CL_0000066 | denotes | epithelial |
T12 | 778-783 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T13 | 1208-1213 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T14 | 1362-1363 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 0-11 | Chemical | denotes | Sphingosine | http://purl.obolibrary.org/obo/CHEBI_16393 |
T2 | 80-91 | Chemical | denotes | Sphingosine | http://purl.obolibrary.org/obo/CHEBI_16393 |
T3 | 205-216 | Chemical | denotes | sphingosine | http://purl.obolibrary.org/obo/CHEBI_16393 |
T4 | 312-323 | Chemical | denotes | sphingosine | http://purl.obolibrary.org/obo/CHEBI_16393 |
T5 | 598-609 | Chemical | denotes | sphingosine | http://purl.obolibrary.org/obo/CHEBI_16393 |
T6 | 628-632 | Chemical | denotes | NaCl | http://purl.obolibrary.org/obo/CHEBI_26710 |
T7 | 811-822 | Chemical | denotes | sphingosine | http://purl.obolibrary.org/obo/CHEBI_16393 |
T8 | 926-937 | Chemical | denotes | sphingosine | http://purl.obolibrary.org/obo/CHEBI_16393 |
T9 | 1069-1076 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T10 | 1113-1124 | Chemical | denotes | sphingosine | http://purl.obolibrary.org/obo/CHEBI_16393 |
T11 | 1316-1327 | Chemical | denotes | sphingosine | http://purl.obolibrary.org/obo/CHEBI_16393 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 249-265 | http://purl.obolibrary.org/obo/GO_0016032 | denotes | viral infections |
T2 | 1148-1164 | http://purl.obolibrary.org/obo/GO_0016032 | denotes | viral infections |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-79 | Sentence | denotes | Sphingosine prevents binding of SARS-CoV-2 spike to its cellular receptor ACE2. |
T2 | 80-266 | Sentence | denotes | Sphingosine has been shown to prevent and eliminate bacterial infections of the respiratory tract, but it is unknown whether sphingosine can be also employed to prevent viral infections. |
T3 | 267-557 | Sentence | denotes | To test this hypothesis, we analyzed whether sphingosine regulates the infection of cultured and freshly isolated ex vivohuman epithelial cells with pseudoviral particles expressing SARS-CoV-2 spike (pp-VSV-SARS-CoV-2 spike) that served as a bona fide system mimicking SARS-CoV-2 infection. |
T4 | 558-686 | Sentence | denotes | We demonstrate that exogenously applied sphingosine suspended in 0.9% NaCl prevents cellular infection with pp-SARS-CoV-2 spike. |
T5 | 687-888 | Sentence | denotes | Pre-treatment of cultured Vero epithelial cells or freshly isolated human nasal epithelial cells with low concentrations of sphingosine prevented adhesion of and infection with pp-VSV-SARS-CoV-2 spike. |
T6 | 889-1087 | Sentence | denotes | Mechanistically, we demonstrate that sphingosine binds to ACE2, the cellular receptor of SARS-CoV-2, and prevents the interaction of the receptor binding domain of the viral spike protein with ACE2. |
T7 | 1088-1232 | Sentence | denotes | These data indicate that sphingosine prevents at least some viral infections by interfering with the interaction of the virus with its receptor. |
T8 | 1233-1423 | Sentence | denotes | Our data also suggest that further preclinical and finally clinical examination of sphingosine is warranted for potential use as a prophylactic or early treatment for coronavirus disease-19. |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
4 | 0-11 | Chemical | denotes | Sphingosine | MESH:D013110 |
5 | 32-42 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
6 | 43-48 | Gene | denotes | spike | Gene:43740568 |
7 | 74-78 | Gene | denotes | ACE2 | Gene:59272 |
38 | 80-91 | Chemical | denotes | Sphingosine | MESH:D013110 |
39 | 132-152 | Disease | denotes | bacterial infections | MESH:D001424 |
40 | 205-216 | Chemical | denotes | sphingosine | MESH:D013110 |
41 | 249-265 | Disease | denotes | viral infections | MESH:D001102 |
42 | 312-323 | Chemical | denotes | sphingosine | MESH:D013110 |
43 | 338-347 | Disease | denotes | infection | MESH:D007239 |
44 | 449-459 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
45 | 460-465 | Gene | denotes | spike | Gene:43740568 |
46 | 474-484 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
47 | 485-490 | Gene | denotes | spike | Gene:43740568 |
48 | 536-556 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 |
49 | 598-609 | Chemical | denotes | sphingosine | MESH:D013110 |
50 | 628-632 | Chemical | denotes | NaCl | MESH:D012965 |
51 | 651-660 | Disease | denotes | infection | MESH:D007239 |
52 | 669-679 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
53 | 680-685 | Gene | denotes | spike | Gene:43740568 |
54 | 755-760 | Species | denotes | human | Tax:9606 |
55 | 811-822 | Chemical | denotes | sphingosine | MESH:D013110 |
56 | 849-858 | Disease | denotes | infection | MESH:D007239 |
57 | 871-881 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
58 | 882-887 | Gene | denotes | spike | Gene:43740568 |
59 | 926-937 | Chemical | denotes | sphingosine | MESH:D013110 |
60 | 947-951 | Gene | denotes | ACE2 | Gene:59272 |
61 | 978-988 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
62 | 1063-1068 | Gene | denotes | spike | Gene:43740568 |
63 | 1082-1086 | Gene | denotes | ACE2 | Gene:59272 |
64 | 1113-1124 | Chemical | denotes | sphingosine | MESH:D013110 |
65 | 1148-1164 | Disease | denotes | viral infections | MESH:D001102 |
66 | 1316-1327 | Chemical | denotes | sphingosine | MESH:D013110 |
67 | 1400-1422 | Disease | denotes | coronavirus disease-19 | MESH:C000657245 |
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-79 | Sentence | denotes | Sphingosine prevents binding of SARS-CoV-2 spike to its cellular receptor ACE2. |
T2 | 80-266 | Sentence | denotes | Sphingosine has been shown to prevent and eliminate bacterial infections of the respiratory tract, but it is unknown whether sphingosine can be also employed to prevent viral infections. |
T3 | 267-557 | Sentence | denotes | To test this hypothesis, we analyzed whether sphingosine regulates the infection of cultured and freshly isolated ex vivohuman epithelial cells with pseudoviral particles expressing SARS-CoV-2 spike (pp-VSV-SARS-CoV-2 spike) that served as a bona fide system mimicking SARS-CoV-2 infection. |
T4 | 558-686 | Sentence | denotes | We demonstrate that exogenously applied sphingosine suspended in 0.9% NaCl prevents cellular infection with pp-SARS-CoV-2 spike. |
T5 | 687-888 | Sentence | denotes | Pre-treatment of cultured Vero epithelial cells or freshly isolated human nasal epithelial cells with low concentrations of sphingosine prevented adhesion of and infection with pp-VSV-SARS-CoV-2 spike. |
T6 | 889-1087 | Sentence | denotes | Mechanistically, we demonstrate that sphingosine binds to ACE2, the cellular receptor of SARS-CoV-2, and prevents the interaction of the receptor binding domain of the viral spike protein with ACE2. |
T7 | 1088-1232 | Sentence | denotes | These data indicate that sphingosine prevents at least some viral infections by interfering with the interaction of the virus with its receptor. |
T8 | 1233-1423 | Sentence | denotes | Our data also suggest that further preclinical and finally clinical examination of sphingosine is warranted for potential use as a prophylactic or early treatment for coronavirus disease-19. |
mondo_disease
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 32-42 | Disease | denotes | SARS-CoV-2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T2 | 132-152 | Disease | denotes | bacterial infections | http://purl.obolibrary.org/obo/MONDO_0005113 |
T3 | 249-265 | Disease | denotes | viral infections | http://purl.obolibrary.org/obo/MONDO_0005108 |
T4 | 338-347 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T5 | 449-459 | Disease | denotes | SARS-CoV-2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T6 | 474-484 | Disease | denotes | SARS-CoV-2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T7 | 536-546 | Disease | denotes | SARS-CoV-2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T8 | 547-556 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T9 | 651-660 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T10 | 669-679 | Disease | denotes | SARS-CoV-2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T11 | 849-858 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T12 | 871-881 | Disease | denotes | SARS-CoV-2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T13 | 978-988 | Disease | denotes | SARS-CoV-2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T14 | 1148-1164 | Disease | denotes | viral infections | http://purl.obolibrary.org/obo/MONDO_0005108 |
T15 | 1400-1422 | Disease | denotes | coronavirus disease-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
NCBITAXON
Id | Subject | Object | Predicate | Lexical cue | db_id |
---|---|---|---|---|---|
T1 | 32-40 | OrganismTaxon | denotes | SARS-CoV | 694009 |
T2 | 449-457 | OrganismTaxon | denotes | SARS-CoV | 694009 |
T3 | 474-482 | OrganismTaxon | denotes | SARS-CoV | 694009 |
T4 | 536-544 | OrganismTaxon | denotes | SARS-CoV | 694009 |
T5 | 669-677 | OrganismTaxon | denotes | SARS-CoV | 694009 |
T6 | 755-760 | OrganismTaxon | denotes | human | 9606 |
T7 | 871-879 | OrganismTaxon | denotes | SARS-CoV | 694009 |
T8 | 978-986 | OrganismTaxon | denotes | SARS-CoV | 694009 |
Anatomy-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 160-177 | Body_part | denotes | respiratory tract | http://purl.obolibrary.org/obo/UBERON_0000065|http://purl.obolibrary.org/obo/UBERON_0000072 |
T3 | 394-410 | Body_part | denotes | epithelial cells | http://purl.obolibrary.org/obo/CL_0000066 |
T4 | 718-734 | Body_part | denotes | epithelial cells | http://purl.obolibrary.org/obo/CL_0000066 |
T5 | 767-783 | Body_part | denotes | epithelial cells | http://purl.obolibrary.org/obo/CL_0000066 |
CL-cell
Id | Subject | Object | Predicate | Lexical cue | cl_id |
---|---|---|---|---|---|
T1 | 394-410 | Cell | denotes | epithelial cells | http://purl.obolibrary.org/obo/CL:0000066 |
T2 | 718-734 | Cell | denotes | epithelial cells | http://purl.obolibrary.org/obo/CL:0000066 |
T3 | 767-783 | Cell | denotes | epithelial cells | http://purl.obolibrary.org/obo/CL:0000066 |